Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jin Medical International Ltd. (ZJYL)
USD2.02
+0.06 (+3.06%)
CN NASDAQ Healthcare Medical - Instruments & Supplies
Address
No. 33 Lingxiang Road
Changzhou, CN
Changzhou, CN
CEO
Erqi Wang
Website
zhjmedical.com
IPO
2023-03-28
CIK 1837821 ISIN KYG5140V1207
Description
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.02
+0.06 (+3.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
283.9K
Beta
7.23
Float Shares
1.83M
Free Float %
23.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.15% | +5.15% | +6.06% | -16.38% | -53.95% | -44.32% | -86.37% | -56.01% | -69.18% | -69.18% | -69.18% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2.02
Quality scores
Altman Z-Score
2.52
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-12.0% Q3'25: +12.9% (vs Q3'23)
-
EPS growth Medical - Instruments & Supplies: +16.3%-68.1% Q3'25: +12.7% (vs Q3'23)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+7.2% Q3'25: -39.2% (vs Q3'23)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+2.9% Q3'25: +9.8% (vs Q3'23)
-
ROIC Medical - Instruments & Supplies: +6.0%+2.8% Q3'25: +19.7% (vs Q3'23)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.1% Q3'25: +0.4% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×20.27× ★ Q3'25: 3.95× (vs Q3'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-4.52M
OE per share TTM
-0.58
Owner's Yield
-24.77%
Maintenance CapEx ratio
344.14%
Maint CapEx / Avg PPE
13.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
88.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Erqi Wang | 107.13M | 68.43% | 107.13M | — | 107.13M | — | IN | China | 2024-02-14 | ↗ |
| 2 | Jolly Harmony Enterprises Limited; EIN: N/A | 95.38M | 60.93% | 95.38M | — | 95.38M | — | CO | British Virgin Islands | 2024-02-14 | ↗ |
| 3 | Er Pu International Limited; EIN: N/A | 11.75M | 7.50% | 11.75M | — | 11.75M | — | CO | British Virgin Islands | 2024-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q4
Investors holding
10
+1 vs prev Q
New positions
4
Closed positions
3
Increased
6
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 117.8K +117.8K (+100.0%) | 25.9K +25.9K (+100.0%) | 0.08% +0.075 pp | 0.00% +0.000 pp | USD0.22 +0.0% | 3 qtrs — |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 106.5K +— (+0.0%) | 23.4K -36.8K (-61.1%) | 0.07% +0.000 pp | 0.00% +0.000 pp | USD3.34 -93.4% | 8 qtrs — |
| 3 | JANE STREET GROUP, LLC | 50.9K +50.9K (+100.0%) | 11.2K +11.2K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD0.22 +0.0% | 4 qtrs — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 40.0K +40.0K (+100.0%) | 8.8K +8.8K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD0.22 +0.0% | 1 qtrs NEW |
| 5 | ADVISOR GROUP HOLDINGS, INC. | 32.0K +9.0K (+39.1%) | 7.0K -9.3K (-56.9%) | 0.02% +0.006 pp | 0.00% +0.000 pp | USD0.89 -75.3% | 8 qtrs — |
| 6 | XTX TOPCO LTD | 28.6K +10.9K (+61.1%) | 6.3K -3.8K (-37.3%) | 0.02% +0.007 pp | 0.00% 0.000 pp | USD0.43 -48.8% | 4 qtrs — |
| 7 | TWO SIGMA SECURITIES, LLC | 22.0K +22.0K (+100.0%) | 4.8K +4.8K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.001 pp | USD0.22 +0.0% | 1 qtrs NEW |
| 8 | UBS GROUP AG | 4.5K -37.2K (-89.2%) | 987.00 -22.6K (-95.8%) | 0.00% -0.024 pp | 0.00% +0.000 pp | USD0.80 -72.5% | 8 qtrs — |
| 9 | BELL INVESTMENT ADVISORS, INC | 152.00 +— (+0.0%) | 34.00 -52.0 (-60.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.60 -91.5% | 7 qtrs — |
| 10 | MORGAN STANLEY | 100.00 -100.0 (-50.0%) | 22.00 -91.0 (-80.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.56 -60.7% | 8 qtrs — |
| 11 | TOWER RESEARCH CAPITAL LLC (TRC) | — -100.0 (-100.0%) | — -56.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 12 | HRT FINANCIAL LP | — -15.5K (-100.0%) | — -8.0K (-100.0%) | 0.00% -0.010 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 13 | MILLENNIUM MANAGEMENT LLC | — -19.6K (-100.0%) | — -11.1K (-100.0%) | 0.00% -0.013 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Wang Ziqiang | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Wang Erqi | Director / Officer / 10% Owner | — | — | Class B Ordinary Shares | 0 | 0.00 | — | 1,000,000 | I | ↗ |
| 2026-03-18 | TONG JAMES JIAYUAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Guo Yanru | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Franklin Oliver St Clair Jr | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
2.3K
Shares Outstanding
7.83M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Erqi Wang | Chairman of the Board, President & Chief Executive Officer | 64.7K | male |
| Ziqiang Wang | Chief Financial Officer & Director | 39.7K | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZJYL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
